These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3129839)

  • 1. The effect of long-term cyclosporine therapy on natural killer cell activity.
    Versluis DJ; Metselaar HJ; Bijma AM; Vaessen LM; Wenting GJ; Weimar W
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):179-85. PubMed ID: 3129839
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporine reversibly inhibits natural killer-cell activity.
    Citterio F; Cauda R; Tumbarello M; Pozzetto U; Ortona L; Castagneto M
    Transplant Proc; 1991 Feb; 23(1 Pt 2):976-7. PubMed ID: 1989350
    [No Abstract]   [Full Text] [Related]  

  • 3. Natural killer activity against viral targets in cyclosporine-treated renal allograft recipients.
    Cauda R; Citterio F; Tamburrini E; Pozzetto U; Tumbarello M; Castagneto M; Ortona L
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):186-9. PubMed ID: 2834839
    [No Abstract]   [Full Text] [Related]  

  • 4. Additive effect of cyclosporine and verapamil on the inhibition of activation and function of human peripheral blood mononuclear cells.
    Weir MR; Peppler R; Gomolka D; Handwerger BS
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):240-4. PubMed ID: 2966479
    [No Abstract]   [Full Text] [Related]  

  • 5. Analysis of lymphokine-activated killer (LAK) cells.
    Ortaldo JR
    Prog Clin Biol Res; 1987; 244():197-206. PubMed ID: 2443928
    [No Abstract]   [Full Text] [Related]  

  • 6. Augmentation of NK cell activity by IL-2.
    Herberman RB
    Prog Clin Biol Res; 1987; 244():267-74. PubMed ID: 3498952
    [No Abstract]   [Full Text] [Related]  

  • 7. Contrasting results of immunological monitoring in cyclosporine- and azathioprine-treated renal allograft recipients.
    Waltzer WC; Arnold AN; Anaise D; Rapaport FT
    Transplant Proc; 1986 Aug; 18(4):970-3. PubMed ID: 3526668
    [No Abstract]   [Full Text] [Related]  

  • 8. Leuprolide vs. diethylstilboestrol: effect on natural killer cells.
    Ablin RJ; Gonder MJ; Bartkus JM
    Anticancer Res; 1988; 8(1):73-6. PubMed ID: 3128959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The differential effects of human leukocyte pyrogen/lymphocyte-activating factor, T cell growth factor, and interferon on human natural killer activity.
    Dempsey RA; Dinarello CA; Mier JW; Rosenwasser LJ; Allegretta M; Brown TE; Parkinson DR
    J Immunol; 1982 Dec; 129(6):2504-10. PubMed ID: 6982930
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of 5-fluorouracil to enhance natural killer activity in rat bone marrow.
    Cramer DV; Harnaha JB; Herberman RB
    Transplant Proc; 1989 Apr; 21(2):3275-6. PubMed ID: 2785307
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical testing of IL-2: in vivo administration of IL-2 induces IL-2 dependent non-MHC-restricted cytotoxicity (NRC).
    Sondel PM; Hank JA; Rosenthal N; Moore KH; Hong R; Storer B; Kohler PC
    Prog Clin Biol Res; 1987; 244():173-84. PubMed ID: 3498947
    [No Abstract]   [Full Text] [Related]  

  • 12. IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes.
    Grönberg A; Ferm MT; Ng J; Reynolds CW; Ortaldo JR
    J Immunol; 1988 Jun; 140(12):4397-402. PubMed ID: 3131433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Natural immunostimulants].
    Nikitin AV; Navashin SM
    Antibiotiki; 1983 Sep; 28(9):702-16. PubMed ID: 6357066
    [No Abstract]   [Full Text] [Related]  

  • 14. Human natural killer cells.
    Trinchieri G; Perussia B; Santoli D; Cerottini JC
    Transplant Proc; 1979 Mar; 11(1):807-10. PubMed ID: 452106
    [No Abstract]   [Full Text] [Related]  

  • 15. NK cell natural cytotoxicity and IFN-gamma production are not always coordinately regulated: engagement of DX9 KIR+ NK cells by HLA-B7 variants and target cells.
    Kurago ZB; Lutz CT; Smith KD; Colonna M
    J Immunol; 1998 Feb; 160(4):1573-80. PubMed ID: 9469412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of natural killer cell activity in random-bred Rowett athymic rats.
    Lotzová E; Savary CA; Stringfellow DA; Drewinko B; Gray KN; Raulston GL; Jardine JH
    Exp Cell Biol; 1984; 52(1-2):53-9. PubMed ID: 6698279
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of various interferons on the spontaneous cytotoxicity exerted by lymphocytes from normal and tumor-bearing patients.
    Lucero MA; Fridman WH; Provost MA; Billardon C; Pouillart P; Dumont J; Falcoff E
    Cancer Res; 1981 Jan; 41(1):294-9. PubMed ID: 6160906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of natural killer cell activity by interferon and interleukin-2 in human large granular lymphocytes inhibited by cyclosporine.
    Ramsey KM; Dyer D; Stocks N; Djeu JY
    Transplant Proc; 1984 Dec; 16(6):1628-31. PubMed ID: 6334388
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell-mediated and glucocorticoid-mediated target cell lysis do not appear to share common pathways.
    Dennert G; Landon C; Nowicki M
    J Immunol; 1988 Aug; 141(3):785-91. PubMed ID: 3260911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.